MOVI Wins Multiple Awards at Vapemagz 2022

Aug.09.2022
MOVI Wins Multiple Awards at Vapemagz 2022
MOVI receives multiple awards at the 2022 Vapemagz Awards, showcasing their widely-accepted products.

In 2022, MOVI received multiple awards at the Vapemagz Awards and is set to create a product that will be accepted by all elements.


Earlier, at the end of 2021, he was awarded the LEPID (World Indonesia Record Achievement Research Institute) award.


In early 2022, MOVI, the leading e-cigarette and e-liquid distributor in Indonesia, was awarded the MURI (Indonesian World Record Museum) award. As the second semester of 2022 began, MOVI once again received multiple innovation awards.


This award was presented by Vapemagz on July 30, 2022 at the Grand Kemang in Jakarta.


Vapemagz is a pioneer in the Indonesian vaping community, serving as a reference for e-cigarette enthusiasts to stay up to date on the latest news in the Indonesian and global e-cigarette industry. It is a media outlet that manufacturers and retailers typically turn to in order to appeal to e-cigarette connoisseurs.


MOVI won three awards, namely:


KUY has been recognized as the most popular local brand for Pod Open System of the year.


沙发 The AFLO herbal series has been named as the most innovative liquid sofa of the year.


NICSAL99+ has been named the runner-up for the most popular type of salt of the year.


Aldi Djemat, the founder of Vapemagz, stated that as a media outlet, they have always supported innovation within the electronic cigarette industry and are proud to present these awards to MOVI.


Statement:


This article has been compiled from third-party information and is intended for industry professionals for educational and informational purposes only.


This article does not reflect the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is intended for communication and research within the industry.


Due to limitations in our translation abilities, the translated article may not fully express the same meaning as the original. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong/Macau/Taiwan-related, or foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

NZ school principal says student vaping has eased markedly from the post-pandemic peak
NZ school principal says student vaping has eased markedly from the post-pandemic peak
Daryl Gibbs, principal of Cambridge Middle School and president of the New Zealand Association of Intermediate and Middle Schools, says student vaping has fallen noticeably over the past two years after a sharp post-COVID surge. At the peak, schools deployed measures such as vape monitors and coordinated responses among principals; today his school is dealing with only a handful of repeat cases. Gibbs backs tighter access rules and stresses families’ primary role in prevention, remarks he made a
Sep.11 by 2FIRSTS.ai
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
A World Health Organization (WHO) official, Dr. Roa, recently questioned the U.S. Food and Drug Administration’s (FDA) scientific assessment of e-cigarettes and nicotine pouches, claiming there was no independent consensus and suggesting its conclusions may have been influenced by the industry. Her remarks contradict the consensus of leading international scientific bodies and are seen as a direct challenge to FDA’s credibility and to the integrity of public health science.
Aug.20 by 2FIRSTS.ai
Observation | As China’s Nicotine Pouch Supply Chain Cools, Market Focus Accelerates Abroad
Observation | As China’s Nicotine Pouch Supply Chain Cools, Market Focus Accelerates Abroad
China’s nicotine pouch sector saw a sharp decline in exhibitors and traffic. Insiders cite tighter regulation and rising overseas competition, with many firms turning to Europe, the U.S., and the Middle East, and some building factories in Indonesia for growth.
Aug.28 by 2FIRSTS.ai
Imperial Responds to 2Firsts: Disappointed by FDA Denial of blu Product
Imperial Responds to 2Firsts: Disappointed by FDA Denial of blu Product
2Firsts interviewed Imperial Brands on FDA’s blu denial. ITG Brands responded with disappointment, vowing to pursue a fair, science-based review.
Aug.22
Experts Make the Case for THR in Asia-Pacific, as Demand, Science, and Industry Drive Its Growth
Experts Make the Case for THR in Asia-Pacific, as Demand, Science, and Industry Drive Its Growth
At the inaugural AFN, Dr. Rohan Sequeira and Dr. Alex Wodak emphasized that THR offers a science-based approach to reduce smoking-related harm—not merely as an alternative to cessation. They urged policymakers across Asia to reassess tobacco control and include non-combustible products in public health strategies. This article outlines the scientific foundation of THR, its regional challenges, and growth momentum.2Firsts provided in-depth coverage of the forum.
Sep.09
Singapore Survey: Over 30% of E-Cigarette Users Buy Through Encrypted Messaging Apps
Singapore Survey: Over 30% of E-Cigarette Users Buy Through Encrypted Messaging Apps
Over 36% of Singapore e-cigarette users buy through encrypted apps like Telegram, helping them evade the country’s 2018 vape ban. As Kpods with etomidate face new restrictions, users may grow more cautious.
Jul.30 by 2FIRSTS.ai